Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study tested a new drug combination (TQB3616 plus anlotinib or standard chemo) in 21 people with advanced lung cancer that had worsened after prior treatments. The goal was to see if the combo could shrink tumors or slow the disease. The study was stopped early, so results a…

This early-stage study tested a new tablet called TQB3720 in 192 men with advanced prostate cancer that had stopped responding to hormone therapy. The goal was to find the safest dose and see how the drug moves through the body. The study was ended early, so results are limited.